Proven Efficacy in Tough-to-Treat Acne
Dual Therapy with Epiduo Forte Gel and Doxycycline 200 mg6*
80% of patients were no longer candidates for oral isotretinoin at end of the ALAMO study6
LOCF=last observation carried forward.
*An open-label, single-arm, investigational, multicenter study of 186 patients with severe acne non-nodulocystic/non-conglobateacne (IGA 4, ≥4 nodules/cysts), candidates for oral isotretinoin according to the opinion of the investigator, using doxycycline 200 mg (two 50 mg tablets twice daily) + Epiduo Forte Gel (once daily) and CETAPHIL® GSC (twice daily) and CETAPHIL DFM SPF 15 (at least once daily and as needed). Primary endpoint was the reduction in inflammatory lesions from baseline (week 0) to week 12.6